Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
A new contact lens for kids is putting the brakes on nearsightedness. Three-year data from a randomized study show that children wearing Acuvue Abiliti 1-Day lenses had dramatically lower myopia progression and axial length growth compared to controls — all while maintaining 20/20 or better vision. The lens isn't FDA approved yet but is already cleared in Canada.
A new contact lens for kids is putting the brakes on nearsightedness. Three-year data presented at Academy 2026 show that children aged 7–12 wearing Acuvue Abiliti 1-Day lenses (Johnson & Johnson) had dramatically lower myopia progression and axial eye growth compared to those wearing standard single-vision lenses. The lens uses a unique multi-zone optical design — including a central 10 D coaxial add power zone and two surrounding 7 D noncoaxial annular zones — to flood the eye with myopic defocus while minimizing the vision quality trade-off that typically limits such lenses.
Of 190 children enrolled, 149 completed the 3-year follow-up with no serious contact lens-related adverse events and no dropouts due to ocular issues.
By the Numbers:
Why it matters: Childhood myopia is a growing global concern, and slowing its progression can reduce the long-term risk of serious eye conditions like retinal detachment and glaucoma. These results support Abiliti 1-Day as a safe, effective option for pediatric myopia management — though U.S. clinicians will need to wait for FDA approval before prescribing it.
